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Molecular Characterization of the viaB Locus Encoding
the Biosynthetic Machinery for Vi Capsule Formation in
Salmonella Typhi
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1 GlycoVaxyn AG, Schlieren, Switzerland, 2 Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom, 3 Department of Molecular
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Abstract
The Vi capsular polysaccharide (CPS) of Salmonella enterica serovar Typhi, the cause of human typhoid, is important for
infectivity and virulence. The Vi biosynthetic machinery is encoded within the viaB locus composed of 10 genes involved in
regulation of expression (tviA), polymer synthesis (tviB-tviE), and cell surface localization of the CPS (vexA-vexE). We cloned
the viaB locus from S. Typhi and transposon insertion mutants of individual viaB genes were characterized in Escherichia coli
DH5a. Phenotype analysis of viaB mutants revealed that tviB, tviC, tviD and tviE are involved in Vi polymer synthesis.
Furthermore, expression of tviB-tviE in E. coli DH5a directed the synthesis of cytoplasmic Vi antigen. Mutants of the ABC
transporter genes vexBC and the polysaccharide copolymerase gene vexD accumulated the Vi polymer within the cytoplasm
and productivity in these mutants was greatly reduced. In contrast, de novo synthesis of Vi polymer in the export deficient
vexA mutant was comparable to wild-type cells, with drastic effects on cell stability. VexE mutant cells exported the Vi, but
the CPS was not retained at the cell surface. The secreted polymer of a vexE mutant had different physical characteristics
compared to the wild-type Vi.
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the absence of a homologue of wzy/wzx respectively. Therefore,
biosynthesis of Vi is thought to be similar to E. coli group 2 CPS
[11].
Vi expression in S. Typhi is under control of the RcsB-RcsC
and OmpR-EnvZ two-component regulator systems [12,13,14]
and when the complete viaB operon is expressed in Escherichia coli
K12 a similar pattern of regulation can also be observed [15].
RcsB-RcsC and OmpR-EnvZ likely interact with TviA and
regions upstream of the tviA promoter thereby linking Vi
expression to environmental signatures such as osmolarity [16].
TviA is an activator of the viaB operon and deletion of the tviA
gene strongly decreases expression of the Vi capsule [17].
Biosynthesis of the Vi polysaccharide takes place in the
cytoplasm and requires functional TviB, TviC, TviD and TviE
proteins [17] (Figure 1B). TviB and TviC are involved in
catalyzing the conversion of UDP-N-acetylglucosamine (UDPGlcNAc) to UDP-N-acetylgalactosaminuronate (UDP-GalNAcA),
which serves as the building block for the assembly of the Vi
polymer [18]. Assembly of the Vi polymer is dependent on
functional expression of tviD and tviE [17]. The enzyme
responsible for O-acetylation of the Vi polysaccharide has not
yet been identified.

Introduction
The causative agent of the human systemic infection typhoid
fever, Salmonella enterica subspecies I serotype Typhi (S. Typhi),
expresses a capsular polysaccharide (CPS) known as Vi antigen
(Vi). The Vi capsule provides S. Typhi with mechanisms to avoid
host defenses [1,2] and it is important in enhancing infectivity and
virulence [3,4,5]. Besides being an important virulence factor, the
Vi is also a protective antigen and a vaccine based on purified Vi
polysaccharide has been developed and licensed for use as a
parenteral vaccine against typhoid fever [6].
Vi is a linear, acidic homopolymer of a-1,4-linked Nacetylgalactosaminuronate (D-GalNAcA), variably O-acetylated
at C-3. The O-acetyl groups make up most of the surface and the
immunogenicity of Vi is closely related to the degree of O
acetylation [7,8]. Key proteins involved in Vi capsule formation
are encoded within a cluster of genes, known historically as the
viaB locus [9], a region located on a 134 kb DNA island, termed
Salmonella pathogenicity island 7 (SPI-7) within S. Typhi [10]. The
S. Typhi viaB constitutes 10 genes involved in regulation of
expression (tviA), biosynthesis (tviB to tviE), and cell surface
localization of the Vi polysaccharide (vexA to vexE) (Figure 1A).
Analysis of the bioinformatics signature of viaB highlighted the
presence of a putative ATP-binding cassette (ABC) transporter and
PLOS ONE | www.plosone.org
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Figure 1. Overview of the viaB operon and Vi capsular polysaccharide biosynthesis pathway. (A) Schematic diagram of the S. Typhi viaB
operon. (B) The Vi antigen is a linear polymer of a-1,4-linked N-acetylgalatosaminuronate, nonstoichiometrically esterified with acetyl groups at the C3. A TviB-catalyzed oxidation of UDP-N-acetylglucosamine (UDP-GlcNAc) followed by the TviC-catalyzed epimerization at the C-4 of UDP-Nacetylglucosaminuronate (UDP-GlcNAcA) results in the formation of UDP-N-acetylgalactosaminuronate (UDP-GalNAcA), the building block for Vi
polymer formation. The Vi polymer is synthesized in the cytoplasm and assembly is dependent on TviD and TviE. The enzyme catalyzing the Oacetylation of the capsular polysaccharide has not yet been identified. Subsequent translocation of the polysaccharide to the cell surface follows an
ATP-binding cassette (ABC) transporter-dependent process. The transporter consists of VexA, VexB, VexC and VexD. The precise function of VexE is
equivocal although it might be involved in anchoring the Vi to the cell surface.
doi:10.1371/journal.pone.0045609.g001

domain. The functional transporter is proposed to consist of two
subunits each of KpsM and KpsT. VexD and its homologous
protein KpsE of E. coli K1 belong to a family called the
polysaccharide copolymerases subfamily 3 (PCP-3) [19]. There is
no structural information yet available about this subfamily but all
PCP proteins have a characteristic membrane topology in which a
large periplasmic loop is flanked by two transmembrane regions
localized in the inner membrane. PCP-3 proteins might provide a
periplasmic scaffold for linking the ABC transporter in the inner
membrane with the OPX protein in the outer membrane
therefore assembling the complete polysaccharide translocation
machinery. VexE seems to be responsible for anchoring the Vi to
the cell surface [17].
To investigate the function of individual proteins involved in
biosynthesis and cell surface expression of the Vi CPS in greater
detail, the viaB cluster was cloned from S. Typhi and transposon
insertion mutants of individual viaB genes were characterized in E.
coli DH5a. A detailed and comprehensive phenotype character-

Cell surface localization of the Vi polymer is dependent on
functional expression of vexA, vexB, vexC, vexD and vexE (Figure 1B).
The predicted lipoprotein VexA belongs to group B of the outer
membrane polysaccharide export (OPX) proteins [19]. OPX
proteins for which a high-resolution structures have been solved
include Wza [20], a protein essential for group 1 CPS expression
on the surface of E. coli and the E. coli group 4 capsule protein
GfcC [21]. The Wza protein forms an octameric structure that
spans the outer membrane and protrudes into the periplasm,
thereby forming a water-filled channel. One of the most
extensively studied bacterial group 2 capsules is the K1 serotype
of E. coli. The E. coli K1 capsular gene cluster encodes KpsD,
which is the functional homologue of VexA. VexBC belong to the
large family of ABC transporters whose members have been
implicated in the transport of substrates across membranes. The E.
coli K1 ABC transporter KpsMT is a close homologue of VexBC
[22]. KpsM is a hydrophobic, integral inner membrane protein
with six transmembrane domains whereas KpsT is a hydrophilic,
peripheral inner membrane protein containing an ATP-binding
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Figure 2. Localization and Quantification of the Vi polysaccharide in different viaB transposon insertion mutants. (A) Washed cell
pellets (wc) and the corresponding supernatants (sn) of DH5a overnight cultures harboring the indicated plasmids were spotted onto nitrocellulose
and blotted with anti-Vi antiserum. (B) Vi content was measured in cell culture supernatants (extracellular Vi), in a suspension of washed and fixed
cells (cell associated Vi), and in cell lysates using a quantitative sandwich ELISA. Intracellular Vi was defined using the difference in Vi measured in cell
lysates and fixed cells. The amount of Vi was normalized to the protein content measured in the cell pellets.
doi:10.1371/journal.pone.0045609.g002

for susceptibility to infection by well characterized Vi phages that are
part of the classical typing set [23,24,25,26,27]. All 7 Vi phage types
were able to infect E. coli DH5a(pGVXN158) but not the plasmid
free controls. Thus, using these simple methodologies the Vi
produced by E. coli was indistinguishable from Vi expressed by the
parenteral S. Typhi. Therefore, this Vi expression system harbored in
E. coli DH5a was used for further analysis of the biosynthetic
machinery assembling the Vi capsule.

ization of viaB single gene mutants and their effect on biosynthesis
and cell surface expression of the Vi CPS is reported here.

Results
Expression of the Vi capsule in E. coli DH5a
The low copy plasmid pGVXN158 was constructed using a
14.9 kb DNA fragment of S. Typhi BRD948 that harbors the 10
open reading frames of the viaB operon with around 900 bp upstream
of the first gene tviA. Therefore the viaB operon contains the natural
regulatory sequences and expression is not controlled by elements
encoded on the plasmid backbone. E. coli DH5a was transformed
with pGVXN158 whereupon the transformants changed colony
morphology towards a smooth colony appearance, indicating the
expression of a capsule. These cells could be agglutinated using a Vi
specific antibody. Furthermore, these encapsulated cells were tested
PLOS ONE | www.plosone.org

Quantification and localization of the Vi in E. coli
DH5a(pGVXN158) harboring single gene transposon
insertions within viaB genes
Next the role of the individual genes of the viaB operon in Vi
capsule expression was analyzed. For this purpose single genes
within the viaB operon encoded on pGVXN158 were inactivated
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by Tn5-mediated transposon insertional mutagenesis. To this end,
viaB single gene insertion mutants in all of the genes except the
regulator tviA were selected and the insertion site was mapped
(Table 1). Washed cell pellets and the corresponding supernatants
of overnight cultures from individual transposon insertion mutants
were spotted onto nitrocellulose membranes and the presence of
the Vi CPS was detected by immunoblotting using a monoclonal
Vi specific antibody. To exclude polar effects on downstream
genes, tviB::Tn5, tviC::Tn5, tviD::Tn5, tviE::Tn5, vexB::Tn5,
vexC::Tn5 transposon insertion mutants were complemented with
the corresponding gene cloned and Vi expression was restored
(data not shown). Detection of Vi polysaccharide in the individual
E. coli DH5a(pGVXN158) transposon mutant derivatives revealed
three distinguishable phenotypes (Figure 2A): i) a strong signal was
detected with cell cultures from E. coli DH5a(pGVXN158) and E.
coli DH5a(pGVXN158) harboring vexA::Tn5 (pGVXN158vexA::Tn5)
ii) an intermediate staining was associated with vexB::Tn5
(pGVXN158vexB::Tn5), vexC::Tn5 (pGVXN158vexC::Tn5), and
vexD::Tn5 (pGVXN158vexD::Tn5), whereas iii) no Vi was detected
in cell cultures of E. coli DH5a carrying the empty plasmid control
pGVXN157 or E. coli DH5a(pGVXN158) harboring tviB::Tn5
(pGVXN158tviB::Tn5), tviC::Tn5 (pGVXN158tviC::Tn5), tviD::Tn5
(pGVXN158tviD::Tn5), tviE::Tn5 (pGVXN158tviE::Tn5) or vexE::Tn5
(pGVXN158vexE::Tn5). To determine if the detection of Vi observed
in the vexA::Tn5, vexB::Tn5, vexC::Tn5 or vexD::Tn5 transposon
insertion mutants was associated with surface expression of
capsular Vi, slide agglutination and Vi phage infections were
performed (Table 1). None of the cells harboring these transposon
insertion mutants could be agglutinated with a Vi specific antibody
and none of the tested mutants could be infected with either one of
the seven Vi phages. Taken together these results indicate that Vi
polysaccharide is still produced in cells expressing the viaB locus
with a transposon insertion in vexA, vexB, vexC and vexD but this is
not cell surface associated.
To generate a more detailed view about the quantities and the
localization of the Vi polysaccharide produced in the different viaB
insertion mutants, a sandwich ELISA was developed. With this
method Vi polysaccharide contents were measured in the cell
culture supernatant (extracellular Vi), in a suspension of washed
cells that were fixed with paraformaldehyde (cell associated Vi),
and in cell lysates. Intracellular Vi was defined using the difference
in Vi measured in cell lysates and fixed cells (Figure 2B).

E. coli DH5a(pGVXN158) cells expressed 6–7 times more Vi
than S. Typhi BRD948, although the cellular distribution of Vi
was similar. Vi was mainly detected on the cell surface, and in the
cell culture supernatant. No Vi was detected in
DH5a(pGVXN158tviC::Tn5),
DH5a(pGVXN158tviB::Tn5),
DH5a(pGVXN158tviD::Tn5),
DH5a(pGVXN158tviE::Tn5)
or
DH5a(pGVXN157). These data confirm the results by Virlogeux
et al. [17] that TviB, TviC, TviD and TviE are involved in the
biosynthesis of the Vi polysaccharide. Vi distribution looked
similar in DH5a(pGVXN158vexB::Tn5), DH5a(pGVXN158vexC::Tn5)
or DH5a(pGVXN158vexD::Tn5) whereas these insertion mutants
produced 15–35 times less Vi in total as compared to
DH5a(pGVXN158). Vi in these mutants was mainly detected
predominantly inside the cells and in the culture supernatants. In
contrast, DH5a(pGVXN158vexA::Tn5) and DH5a(pGVXN158vexE::Tn5) produced large amounts of Vi the former in the same
magnitude range as DH5a(pGVXN158) whereas the vexE::Tn5
mutant produced approximately half the amount of the total Vi
measured in DH5a cells expressing the wild type viaB locus.
However, cellular distribution of the Vi in these two insertion
mutants was different. In DH5a(pGVXN158vexA::Tn5) cultures,
slightly lower amounts of Vi were detected in the cell culture
supernatant, whereas comparable amounts of intracellular and cell
associated Vi was measured. The detection of surface exposed Vi
in this viaB insertion mutant is potentially in conflict with the
observed resistance of this strain to Vi phage infection and the fact
that it is not agglutinable with a Vi antigen specific antibody. The
Vi produced by cells harboring a vexE transposon insertion
plasmid was mainly localized in the cell culture supernatant with
similar amounts comparable to DH5a(pGVXN158). However, in
contrast to DH5a(pGVXN158), only low levels of intracellular
and cell surface associated Vi was detectable. This result indicates
that the vexE mutant expresses a functional Vi translocation
machinery, but once the polymer is exported, the Vi is not
efficiently retained on the cell surface.

Characterization of vex transposon insertion mutants by
transmission electron microscopy and immunogold
labeling of the Vi
In addition to the Vi quantification and localization studies by
ELISA, several selected vex transposon insertion mutants were

Table 1. Overview of transposon insertion mutants analyzed in this study.

Plasmid

Tn5 insertion site*

Immunoblotting

Agglutination

Phage infection**

pGVXN157

2

2

2

2

pGVXN158

2

+++

+

+

pGVXN158tviB::Tn5

679/1278

2

2

nd

pGVXN158tviC::Tn5

268/1047

2

2

nd

pGVXN158tviD::Tn5

1909/2496

2

2

nd

pGVXN158tviE::Tn5

388/1737

2

2

nd

pGVXN158vexA::Tn5

350/1068

++

2

2

pGVXN158vexB::Tn5

679/795

+

2

nd

pGVXN158vexC::Tn5

515/696

+

2

2

pGVXN158vexD::Tn5

820/1305

+

2

nd

pGVXN158vexE::Tn5

1247/1971

2

2

2

*bp of insertion site from 39 end of the gene/total length of gene.
**nd: not determined.
doi:10.1371/journal.pone.0045609.t001
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analyzed by transmission electron microscopy (TEM) and immunogold labeling of the Vi polysaccharide using the monoclonal antiVi antibody P2B1G2/A9 [28]. The specificity of the antibody was
tested by immunogold labeling of DH5a cells carrying the empty
plasmid pGVXN157 (Figure 3E). These cells do not express the Vi
polysaccharide and practically no staining was observed. Figure 3A
shows the normal cellular distribution of the Vi antigen in
DH5a(pGVXN158). The images show encapsulated bacteria where
the polysaccharide is mainly localized at the cell surface, but Vi
antigen is also detectable in the periplasmic space and inside
inclusion-like bodies within the cytoplasm.
As expected, the Vi polysaccharide was differently distributed
within the cells carrying viaB transposon insertion mutant
plasmids. In cells harboring vexA::Tn5 encoding a nonfunctional
outer membrane polysaccharide export (OPX) protein, the Vi was
mainly stained within large inclusion-like bodies and sometimes
clustered at the inside of the inner membrane (Figure 3B). Vi
accumulation at the cytoplasmic membrane might indicate the site
of Vi translocation over the inner membrane or an accumulation
due at a blocked pore complex. Very occasional labeling of
filamentous Vi erupting externally from the cell surface was
observed.
In cells expressing a nonfuctional ABC transporter ATPbinding protein VexC, DH5a(pGVXN158vexC::Tn5), the Vi was
labeled in large inclusion-like bodies inside the cells (Figure 3C).
Disruption of the transport motor in this mutant appears to
completely block Vi translocation through the pore complex.
Cells harboring the vexE::Tn5 plasmid display a similar
phenotype as seen in the vexC::Tn5 insertion mutant (Figure 3D).
Vi was mainly stained within inclusion-like bodies inside the cells.
The extracellular Vi detected by ELISA was not visualized in the
extracellular spaces.

Defect of the outer membrane polysaccharide export
(OPX) protein VexA results in cell instability
It was unexpected to detect large amounts of Vi in the cell
culture supernatant and on the cell surface of E. coli harboring the
vexA::Tn5 mutant derivative. In TEM only very occasionally cell
surface associated Vi could be detected (Figure 3B) whereas using
ELISA and immunoblotting (Figure 2) nearly wild-type levels of
surface exposed capsular sugar were detected. One hypothesis to
explain these observations would be, that cells have a functional
transporter in the inner membrane but lack the outer membrane
pore might show potential leakiness, therefore releasing the Vi
from these instable cells. To test this hypothesis we analyzed the
presence of a cytosolic protein, GroEL, in the cell culture
supernatant of individual vex mutants. Therefore, cells of an
overnight culture equivalent to an A600 of 1 were collected and
proteins were precipitated from the supernatant with trichloroacetic acid. Samples that were hereby normalized to the optical
density of the overnight culture were separated by SDS-PAGE and
GroEL was detected by western blot using an anti-GroEL
antibody (Figure 4). As expected, GroEL was mainly detected in
the cell pellet and not in the cell culture supernatant of E. coli
DH5a(pGVXN158). There were only traces of GroEL detectable
in
the
supernatants
of
DH5a(pGVXN158tviB::Tn5),
DH5a(pGVXN158vexB::Tn5),
DH5a(pGVXN158vexC::Tn5),
DH5a(pGVXN158vexD::Tn5) and DH5a(pGVXN158vexE::Tn5). In
contrast, large amounts of GroEL were detected in the supernatant of DH5a(pGVXN158vexA::Tn5) cultures. These data indicate
that in this mutant derivative a propensity for cell instability does
exist. Therefore, the Vi detectable in the ELISA gives an
impression of surface associated polysaccharide, when in fact the
Vi originated from lysed cells. This explanation is also in
PLOS ONE | www.plosone.org

Figure 3. Transmission electron micrographs of ultrathin
sections from E. coli DH5a expressing the Vi polysaccharide.
The Vi has been labeled with the immunogold technique by using an
anti-Vi antibody. (A) E. coli DH5a cells expressing the wild-type viaB
operon (pGVXN158) are shown. The Vi is mainly localized on the cell
surface (CS) but is also stained in the periplasmic space (PP) and inside
inclusion-like bodies within the cytoplasm (IB). (B) E. coli DH5a cells
containing the viaB operon with a transposon insertion in vexA
(pGVXN158vexA::Tn5), the outer membrane polysaccharide export (OPX)
protein, are shown. Vi was mainly stained within large inclusion-like
bodies (IB) and sometimes clustered at the inside of the inner
membrane (CM). Very occasionally, filamentous Vi erupting from the
cell surface was labeled. (C) E. coli DH5a cells containing the viaB
operon with a transposon insertion in vexC (pGVXN158vexC::Tn5), the ATPbinding protein of the ABC transporter, are shown. The Vi polysaccharide was labeled in large inclusion bodies in the cytoplasm. (D) E. coli
DH5a cells containing the viaB operon with a transposon insertion in
vexE (pGVXN158vexE::Tn5) are shown. The Vi polysaccharide was labeled
in large inclusion bodies in the cytoplasm. (E) As a control E. coli DH5a
cells containing the empty plasmid pGVXN157 are shown.
doi:10.1371/journal.pone.0045609.g003

agreement with the inability to agglutinate DH5a(pGVXN158vexA::Tn5) cells, or infect these cells with a Vi phage.

Size exclusion chromatography of exported Vi produced
by E. coli DH5a(pGVXN158) and a vexE::Tn5 transposon
insertion mutant
The observed inability of Vi expressed by DH5a(pGVXN158cells to bind to nitrocellulose membranes or form a

vexE::Tn5)
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Figure 4. Detection of the cytosolic protein GroEL in cell
culture supernatants of individual vex mutants. Either whole cells
(wc) or supernatants (sn) of DH5a cell cultures carrying the indicated
plasmids were separated by SDS-PAGE and after transfer to a
nitrocellulose membrane, GroEL was detected by western blot using
an anti-GroEL antibody. Supernatant samples were normalized by TCA
precipitation to the optical density of the cell culture. In DH5a cells
expressing the wild-type viaB operon (pGVXN158), GroEL is mainly
detected in the cell pellet. In contrast, the supernatant of a vexA
transposon insertion mutant (pGVXN158vexA::Tn5) contains substantial
amounts of the cytosolic marker protein, indicating cell instability.
doi:10.1371/journal.pone.0045609.g004

Figure 5. Size exclusion chromatography of exported Vi
produced by wild type and vexE transposon insertion mutant.
DH5a(pGVXN158) and DH5a(pGVXN158vexE::Tn5) cells were metabolically
labeled with [3H]GlcNAc and the Vi polysaccharide was purified from
the cell culture supernatants. Purified [3H]Vi polysaccharide was
analyzed by size exclusion chromatography using a Sephacryl S-1000
column. The elution profiles of the [3H]Vi preparations are shown. The
void volume (vo) and the inclusion volume (vi) of the column are
indicated.
doi:10.1371/journal.pone.0045609.g005

capsule once transported to the cell surface lead to the hypothesis,
that this polymer might have different physical properties
compared to the wild-type polysaccharide. To further characterize
these different Vi polymer species we radiolabeled the Vi and
separated the purified polymers by size exclusion chromatography.
DH5a(pGVXN157), DH5a(pGVXN158) or DH5a(pGVXN1583
vexE::Tn5) cells were metabolically labeled with [ H]GlcNAc and Vi
polysaccharide was purified from the cell culture supernatants.
There was around 600–700 times more incorporation of
radioisotopes into samples purified from cell cultures expressing
Vi than from cells carrying the empty plasmid, indicating that the
Vi polysaccharide has been labeled specifically (Table 2). Subsequently, [3H]Vi was analyzed by size exclusion chromatography
using a Sephacryl S-1000 column. The elution profile revealed
that the Vi produced by the vexE::Tn5 mutant derivative is clearly
distinguishable from the one produced by E. coli
DH5a(pGVXN158) (Figure 5). The wild-type Vi appears to have
a uniform size distribution and the molecular size of the Vi
polysaccharide was estimated to be 26103 kDa against dextran
standards. The Vi polymer secreted by the vexE::Tn5 mutant
derivative displayed a tailing of the peak in the earlier elution
fractions indicating the presence of either longer polysaccharide
chains or the presence of a polymer with a different Stokes
radius.

derivative could be due to a different degree of O-acetylation. We
therefore determined O-acetyl contents of Vi produced by S.
Typhi BRD948, E. coli DH5a(pGVXN158), DH5a(pGVXN158vexC::Tn5) or DH5a(pGVXN158vexE::Tn5). Vi polysaccharide of these
derivatives was purified either from the cell culture supernatant (in
S. Typhi BRD948, DH5a(pGVXN158) and DH5a(pGVXN158vexE::Tn5)) or from cell lysates (in DH5a(pGVXN158vexC::Tn5)). The
O-acetyl content of the purified Vi preparations was then
measured by the alkaline hydroxylamine method of Hestrin
[30]. The average values of the O-acetyl content from three
separate preparations are presented in Table 3. The O-acetyl
content was comparable in all different derivatives, being around
2.5 mmol per gram of dried Vi polysaccharide, which corresponds
to a level of O-acetylation of around 60%. These data show that
the Vi produced in E. coli has a similar O-acetyl content as the Vi
expressed by S. Typhi. The undistinguishable levels of Oacetylation of Vi purified from the cell lysate of
DH5a(pGVXN158vexC::Tn5) indicates that the O-acetylation reaction takes place in the cytosol and that the reaction is independent
of polymer translocation. Furthermore, the inability of
DH5a(pGVXN158vexE::Tn5) to form a capsule does not correlate
with different levels of O-acetylation of the Vi polymer.

O-acetyl content of the Vi polysaccharide
The ability of a Vi phage to infect a cell is dependent on the
expression of a Vi capsule that is partially O-acetylated at the C-3
position of the N-acetylgalactosaminuronic acid polymer [29]. The
bacterial enzyme responsible for this Vi polysaccharide modification has not yet been identified. PFAM analysis and other
bioinformatics interrogations of the proteins encoded in the viaB
locus did not identify a potential acetyltransferase gene. This
suggests that any acetylase is located outside the viaB operon. The
observation that a Vi phage is able to infect DH5a(pGVXN158)
cells implies, that it is well O-acetylated. Furthermore, we
speculated that the different elution profiles observed in the size
exclusion chromatographic analysis of Vi produced by E. coli
DH5a(pGVXN158) and a vexE::Tn5 transposon insertion mutant
PLOS ONE | www.plosone.org

Table 2. Incorporation of [3H] into purified samples (counts/
total mg protein).

Strain

cpm mg21 protein

DH5a(pGVXN157)

459.1

DH5a(pGVXN158)

325’984.4

DH5a(pGVXN158vexE::Tn5)

281’563.9

doi:10.1371/journal.pone.0045609.t002
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Discussion

Vi productivity in E. coli DH5a(pGVXN158) is higher
compared to S. Typhi BRD948

Typhoid fever remains a serious public health problem in many
developing countries, with, according to conservative WHO
estimates, 16 million cases occurring each year, including about
600,000 deaths. The Vi capsule plays an important role in S.
Typhi virulence by increasing the infectivity of the pathogen and
the severity of the disease. Parenteral vaccines based on purified Vi
CPS have been licensed and are widely used. Yet, many aspects of
the biosynthesis, export and capsule formation of this important
polysaccharide remain unclear. Here, a detailed molecular
characterization of the viaB operon, encoding the biosynthetic
machinery for Vi capsule formation is reported.

It was observed that E. coli cells expressing the wild-type viaB
operon produce around 6–7 times more Vi than S. Typhi
BRD948. This observation could be explained by the presence of
the viaB cluster in different copy numbers in the particular
expression systems. The pLAFR1 plasmid derivative that contains
the viaB cluster is reported to be present in 5–7 copies per cell [34],
whereas S. Typhi BRD948 holds a single viaB operon. Furthermore, spontaneous loss of SPI-7 in Vi-negative S. Typhi has been
reported in stored isolates [35]. The robust plasmid borne
expression of the Vi might additionally account for the difference
seen in CPS productivity. The observed high efficiency of wildtype Vi polysaccharide production in E. coli makes this strain a
good model system to characterize Vi capsule formation and an
interesting Vi production system.

O-acetylation of the Vi
The Vi CPS is a linear, acidic homopolymer of a-1,4-linked Nacetylgalactosaminuronate (D-GalNAcA), 60–90% O-acetylated
at the C-3. The bulky nonpolar O-acetyl groups make up most of
the surface of the Vi and complete O-deacetylation eliminates the
immunogenicity of this CPS [7]. The bacterial enzyme capable of
introducing this modification in the Vi has not yet been described.
PFAM analysis of the proteins encoded in the viaB operon did not
identify an O-acetyltransferase domain, indicating that the gene is
located outside the viaB cluster in the S. Typhi genome. This
situation has been demonstrated for the phase-variable Oacetylation of the group 2 capsule of E. coli K1. In this bacteria
the modification is catalyzed by a prophage encoded Oacetyltransferase that is not linked to the capsular cluster [31].
Clearly the viaB operon can be functionally expressed in E. coli
[15,32]. However, the Vi expressed in E. coli has not yet been
thoroughly characterized and the presence of O-acetyl modifications was equivocal. We found that the Vi produced in E. coli is
recognized by Vi phage types I–VII, thereby converting E. coli into
a Vi phage susceptible bacteria. Recognition of Vi polymer by a Vi
phage is dependent on the presence of O-acetyl groups at the C-3
position of the N-acetylgalactosaminuronate (GalNAcA) building
blocks and it has been shown that phage particles have
deacetylating properties [29]. A conserved protein domain
carrying an acetyl esterase was found to be associated with at
least one tail fiber gene for all Vi phages [33]. This implies that in
contrast to the tip enzymes of K1 or K5 phages, that degrade the
polysaccharide backbone, the Vi phages specifically target the
acetyl modification on the sugar polymer. Besides the observed
susceptibility to Vi phage infection, we could show through
chemical analysis that the Vi produced in E. coli is substantially Oacetylated. In addition, a similar degree of O-acetylation could be
measured in an intracellular Vi preparation produced by a
transporter deficient mutant (DH5a(pGVXN158vexC::Tn5)), indicating that O-acetylation is taking place in the cytoplasm and that
it is a translocation independent process.

tviBCDE is the minimal set of genes required for Vi
polysaccharide synthesis
Our data confirm the results obtained by Virlogeux et al., 1995,
that TviB, TviC, TviD and TviE are required for Vi polymer
assembly. Firstly, no Vi could be detected in these individual
transposon insertion mutants. Secondly, intracellular Vi was
identified in E. coli cells carrying a plasmid encoding tviBCDE
(results not shown). The latter result indicates that the Vi polymer
is assembled in the cytoplasm and that assembly is independent of
the translocation machinery. Similar results have been obtained
with the well-characterized group 2 capsule of E. coli K1. It has
been shown that cells harboring a plasmid encoding the
biosynthetic region-2 genes alone can synthesize intracellular
polysialic acid [36]. Additionally, synthesis of full-length polymer
has been shown to occur in vitro and in a variety of transportdeficient backgrounds in vivo [37,38].

Synthesis and export of the Vi polysaccharide seem to be
coupled processes
It appears to be common to group 2-like capsules that
biosynthesis of intracellular polymer is independent of the sugar
export machinery. However, Vi quantification in the different
vex::Tn5 transposon insertion mutants that encode the CPS
transporter (vexABCD) by ELISA demonstrated different productivity in the individual mutants. Whereas DH5a(pGVXN158vexA::Tn5) expressed almost wild-type levels of Vi, the CPS productivity in DH5a(pGVXN158vexB::Tn5), DH5a(pGVXN158vexC::Tn5)
and DH5a(pGVXN158vexD::Tn5) was greatly reduced. This result
indicates that synthesis and export of the Vi are coupled processes.
A reduction in endogenous glycosyltransferase activity has also
been shown for E. coli K1 cells harboring export defects [22,37].
Moreover, the formation of a hetero-oligomeric complex consisting of both biosynthetic and export machinery has been
demonstrated in E. coli K5 [39] and E. coli K1 [40]. It is possible
that the predicted inner membrane associated components of the
Vi transporter (VexB, VexC and VexD) interact with the
cytoplasmic based biosynthetic machinery and that disruption of
the transporter indirectly decreases biosynthesis of the Vi polymer
by unknown mechanisms. It seems that this observed negative
feedback mechanism between a non-functional exporter and the
biosynthesis of Vi polymer does not exist when the outer
membrane polysaccharide export protein VexA is nonfunctional.
These mutant cells produce almost wild-type amounts of CPS.
Furthermore, the Vi could sometimes be detected clustered against
the inner membrane by transmission electron microscopy in
DH5a(pGVXN158vexA::Tn5) cells, which might indicate the forma-

Table 3. O-acetyl content of Vi.

Strain

O-acetyl content (mmol g21)

S. Typhi BRD948

2.460.2

DH5a(pGVXN158)

2.760.2

DH5a(pGVXN158vexC::Tn5)

2.560.3

DH5a(pGVXN158vexE::Tn5)

2.460.2

doi:10.1371/journal.pone.0045609.t003
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tion of a functional complex between inner membrane export and
biosynthesis components. Nevertheless, periplasmic accumulations
of Vi could not be detected in these mutant cells as it has been
described for E. coli K1 and K5 mutations in the homologous gene
kpsD [41,42].
DH5a(pGVXN158vexC::Tn5) cells accumulated the Vi polysaccharide in large intracellular, inclusion-like bodies as seen by
transmission electron microscopy. This phenotype has also been
described in E. coli K1 [38,43]. However, inactivation of the E. coli
K1 ABC transporter protein KpsT, resulted in a slightly different
localization of the K1 polymer within the cell, where it
accumulated at discrete sites around the periphery of the cells,
located against the cytosolic membrane.

properties are due to a different degree in O-acetylation because in
both Vi preparations a similar O-acetyl content was determined.
However, these observations might be explained by a lipid
modification that is introduced by the acyltransferase-like enzyme
VexE. In addition, the polysaccharide produced by a vexE::Tn5
mutant displays a broader size distribution compared to the wildtype Vi on a Sephacryl S-1000 column. This lipid modification
might lead to a different stoke radius, explaining the different
behavior in size exclusion chromatography. It is equivocal if the
observed phenotype of a vexE mutant plays a biological role. It
might be possible that S. Typhi can switch between a capsule
producing and a Vi secreting state during different stages of
pathogenesis by regulating VexE activity. The precise function of
VexE in Vi capsule formation should be addressed in future
research.

High Vi expression and non-functional export machinery
results in cell instability

Conclusions

Our data clearly demonstrate that the high levels of Vi
produced in DH5a(pGVXN158vexA::Tn5) cells is not cell surface
exposed. These cells can neither be agglutinated using Vi specific
antisera nor be infected by a Vi phage. In addition, transmission
electron microscopy pictures of these mutant cells do not show a
capsule but intracellular accumulations of the Vi polymer.
Substantial amounts of the cytosolic protein GroEL could be
detected in the cell culture supernatant, indicating that large
amounts of Vi produced by this export deficient mutant destabilize
the cell. The Vi detected in the cell culture supernatant and in
fixed cells by ELISA and immunoblot represents therefore not
translocated but rather released polysaccharide from lysed cells. In
transporter deficient mutants showing reduced Vi assembly
activity (DH5a(pGVXN158vexB::Tn5), DH5a(pGVXN158vexC::Tn5)
and DH5a(pGVXN158vexD::Tn5)) less GroEL was detected in the
cell culture supernatant compared to the vexA::Tn5 transposon
insertion mutant. It seems that the level of Vi biosynthesis in
transporter deficient mutants correlates with cell instability. The
observed destabilizing effect of intracellular CPS accumulations on
cell integrity also underlines the necessity that assembly and export
have to be coupled and coordinated processes. However, the
observed phenotype of a vexA mutant might be less pronounced in
a S. Typhi where the Vi polysaccharide is not overexpressed.

In summary, we conclude that the Vi capsule biosynthesis shows
many characteristics that are typical for group 2-like capsules. The
Vi is completely assembled in the cytoplasm by the gene products
of tviBCDE, and is subsequently transported to the cell surface by
an ABC transporter encoded by vexABCD, that closely resembles
the transporters of the Haemophilus influenzae type b and Neisseria
meningitides group B CPSs. However, several genes indicative for E.
coli group 2 capsular gene clusters, like kpsFU and kpsSC, that are
believed to be involved in CMP-Kdo synthesis and the speculative
addition of a diacylglycerophosphate-Kdo to the CPS [11], are
absent in the viaB operon. In contrast, the viaB operon contains a
gene, vexE, uniquely found in this cluster and possibly involved in
lipidation of the Vi polysaccharide. Despite sharing the basic
mechanism of group 2-like capsule formation, biosynthesis of the
Vi capsule displays features uniquely found in this cell surface
structure.

Materials and Methods
Strains, plasmids, and culture conditions
All bacterial strains and plasmids used in this study are listed in
Table 4. Construction of the plasmids is described below. E. coli
DH5a and EC100 were grown in LB medium (10 g tryptone, 5 g
yeast extract, and 5 g NaCl per liter) or on LB agar (LB medium
with the addition of 15 g agar per liter) at 37uC. S. Typhi BRD948
[44] was grown in LB medium supplemented with 1% v/v Aromix (40 mg L-phenylalanine, 40 mg L-tryptophan, 10 mg 4aminobenzoic acid, and 10 mg 2,3-dihydroxybenzoic acid in
10 ml of ddH2O) and 1% v/v Tyr-mix (40 mg L-tyrosine
disodium salt in 10 ml ddH2O) at 37uC. If appropriate, the media
contained tetracycline (20 mg ml21), trimethoprim (100 mg ml21),
or kanamycin (50 mg ml21). Cells containing pEXT22 derivatives
were grown in the presence of 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG).

Retention of the Vi polysaccharide on the cell surface is
dependent on VexE
VexE shows no homologies to other proteins encoded in group
2-like capsular gene clusters and it is exclusively found in the viaB
operon. PFAM analysis of VexE identified a C-terminal
acyltransferase domain also found in HtrB (LpxL), an enzyme
involved in Kdo2-Lipid A biosynthesis. Vi quantification by
ELISA demonstrated, that Vi production in DH5a(pGVXN158vexE::Tn5) cells was only slightly decreased compared to E. coli cells
expressing the wild-type viaB operon. The Vi polysaccharide
produced by a vexE::Tn5 mutant is mainly found in the cell culture
supernatant as determined by ELISA. There was no Vi visualized
in the extracellular spaces by TEM and immunogold labeling, but
this could be lost during sample preparation. Together, these
results indicate that the Vi in a vexE::Tn5 mutant is efficiently
transported to the cell surface, but once translocated, the
polysaccharide is not retained on the cell surface but is rather
secreted. Therefore these mutant cells can neither be agglutinated
using Vi specific antisera nor be infected by a Vi phage. Besides
the observed inability of this Vi species to form a capsule, the
polysaccharide also does not bind to nitrocellulose membranes,
indicating that this species has different physical characteristics
compared to the wild type Vi. We can rule out that the observed
PLOS ONE | www.plosone.org

DNA manipulations
Plasmid DNA was isolated using the NucleoSpin Plasmid or
NucleoBond Xtra Maxi Plus kit (Macherey-Nagel). Total chromosomal DNA was isolated using NucleoSpin Tissue kit
(Macherey-Nagel). Restriction enzymes (Fermentas), shrimp alkaline phosphatase (Fermentas), T4 DNA ligase (Fermentas), and
Phusion High-Fidelity DNA polymerase (Finnzyme) were used
according to the manufacturer’s instructions. PCR and restriction
fragments were purified for cloning using the NucleoSpin Extract
II kit (Macherey-Nagel). All DNA sequencing was completed by
Synergene Biotech GmbH (Switzerland) and synthetic oligonucleotides were ordered at Microsynth AG (Switzerland).
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Table 4. Strains and plasmids used in this study.

Strain

Genotype or relevant description

Reference

S. Typhi BRD948

S. Typhi Ty2 DaroC DaroD

[44]

E. coli DH5a

K-12 Q80dlacZDM15 endA1 recA1 hsdR17(rK2mK) supE44 thi-1 gyrA96 relA1
D(lacZYA-argF)U169 F2

Clonetech

E. coli EC100

F2 mcrA D(mrr-hsdRMS-mcrBC) W80dlacZDM15 DlacX74 recA1 endA1 araD139
D(ara, leu)7697 galU galK l2 rpsL nupG

Epicentre

Plasmid

Genotype or relevant description

Reference
R

[34]

pLAFR1

low copy-number broad host-range cosmid cloning vector; Tet

pGVXN157

pLAFR1 derivative with multiple cloning site inserted in EcoRI site

This study

pGVXN158

pGVXN157 derivative carrying viaB operon of S. Typhi BRD948 on an AscI/SpeI
fragment; TetR

This study

pGVXN209

pGVXN158 with tviB::Tn5 insertion (pGVXN158tviB::Tn5); TetR, TmpR

This study

pGVXN224

pGVXN158 with tviC::Tn5 insertion (pGVXN158tviC::Tn5); TetR, TmpR

This study

pGVXN198

pGVXN158 with tviD::Tn5 insertion (pGVXN158tviD::Tn5); TetR, TmpR

This study

pGVXN200

pGVXN158 with tviE::Tn5 insertion (pGVXN158tviE::Tn5); TetR, TmpR

This study

pGVXN225

pGVXN158 with vexA::Tn5 insertion (pGVXN158vexA::Tn5); TetR, TmpR
R

This study

pGVXN227

R

pGVXN158 with vexB::Tn5 insertion (pGVXN158vexB::Tn5); Tet , Tmp

This study

pGVXN201

pGVXN158 with vexC::Tn5 insertion (pGVXN158vexC::Tn5); TetR, TmpR

This study

pGVXN202

pGVXN158 with vexD::Tn5 insertion (pGVXN158vexD::Tn5); TetR, TmpR

This study

pGVXN204

pGVXN158 with vexE::Tn5 insertion (pGVXN158vexE::Tn5); TetR, TmpR

This study

doi:10.1371/journal.pone.0045609.t004

pGVXN158 contains the viaB cluster cloned into the pLAFR1
[34] derivative pGVXN157. pGVXN157 contains a synthetic
oligonucleotide cassette formed from annealing of 59AATTGGCGCGCCCGGGACTAGTCTTGGG
and
59AATTCCCAAGACTAGTCCCGGGCGCGCC ligated into the
EcoRI-digested pLAFR1 therefore introducing unique AscI and
SpeI single restriction sites. The viaB gene cluster was amplified
from genomic DNA prepared from S. Typhi BRD948 using the
primers 59- AAAGGCGCGCCGGAGTATCAGTGTGGGGCATAATC and 59- AAAACTAGTGGCCATGAGTCTGAAGCCAGGAGGAATT. The viaB cluster containing PCR
fragment was inserted into the AscI/SpeI digested pGVXN157
therefore producing pGVXN158.

After washing the membranes 36with PBST the membranes were
incubated with a horseradish peroxidase labeled goat anti-mouse
IgG (Sigma, A9824) diluted 1:2000 in 1% milk in PBST.
Membranes were developed using 3,39,5,59-tetramethylbenzidine
(TMB) liquid substrate system for membranes (Sigma). Plasmid
DNA of Vi negative colonies or colonies that appeared to have a
reduced expression of the Vi capsule was isolated and the
transposon insertion site was mapped by sequencing out of the EZTn5 ,DHFR-1. transposon using primers DHFR-1 RP-1 and
DHFR-1 FP-1 provided with the EZ-Tn5 transposon insertion kit.
Single gene insertion mutants of every gene of the viaB cluster
except tviA were selected. In all the selected mutants the coding
strand of the transposon encoded dhfr-1 gene was identical to the
coding strand of the genes in the viaB cluster.

Transposon insertion mutagenesis and screening of viaB
insertion mutants

Antibody detection of Vi antigen on washed cells and in
cell culture supernatants

In vitro transposon insertion mutagenesis was done with
pGVXN158 containing the viaB cluster using the EZ-Tn5
,DHFR-1. insertion kit (Epicentre Biotechnologies, Madison
WI 53713, U.S.A.) according to manufacturer’s instructions. The
in vitro transposon insertion reaction was transformed into
TransforMax EC100 electrocompetent E. coli (Epicentre) and
insertion mutants were selected for the marker encoded by the EZTn5 transposon (dihydrofolate reductase gene (dhfr-1)) on trimethoprim containing plates. To identify transposon insertions into
single genes of the viaB cluster the library was screened for Vi
negative colonies. Therefore a colony blot was performed.
Transformants were transferred to a nitrocellulose membrane.
After washing the membrane 36 with PBST (PBS, 0.1% Tween
20) for 10 min the membranes were blocked by incubating with
10% milk in PBST for 1 h on a shaker at room temperature (RT).
Membranes were incubated with a monoclonal anti Vi antibody
(P2B1G2/A9, [28]) diluted 1:100 in 1% milk in PBST for 1 h.

Overnight cultures were centrifuged and the supernatant was
separated from the cell pellet. The cells were washed 36 with PBS
and finally resuspended in an equal volume of PBS. 100 ml of cell
culture supernatant and washed cells were pipetted onto
nitrocellulose, and the membranes were blocked for 1 h at room
temperature in 10% milk in PBST (PBS, 0.1% Tween 20). The
presence of Vi was detected by using a monoclonal anti Vi
antibody (P2B1G2/A9, [28]) as the primary antiserum, followed
by horseradish peroxidase labeled goat anti-mouse IgG (Sigma,
A9824). Membranes were developed using 3,39,5,59-tetramethylbenzidine (TMB) liquid substrate system for membranes (Sigma).

Plasmid constructions

PLOS ONE | www.plosone.org

Sample preparation for measuring Vi content by ELISA
1 ml of an overnight culture was centrifuged 5 min at 20’000 g
using an eppendorf microcentrifuge. The supernatant was
separated from the cell pellet and used to measure Vi content.
The pellet was washed 36 with PBS and divided into two
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sonicated cells that were treated with proteinase K and nucleases
(in strain DH5a(pGVXN158vexC::Tn5)). Vi was precipitated from
the supernatant or enzyme treated cell lysate with 0.1%
hexadecyltrimethylammonium bromide (CTAB, Sigma, H6269).
20 g l21 celite 545 (Sigma, 20199-U) was added and the mixture
was stirred for 1 h at RT in order to allow the formation of a
polysaccharide-CTAB complex, which adsorbs onto the celite.
The celite was poured into a reservoir of appropriate size (Extractclean EV SPE Reservoir, Socochim S.A.) equipped with a frit
(Socochim S.A.). The column was washed successively by gravity
flow with 10 column volumes (CV) of 0.05% CTAB, 10 CV of
20% ethanol, 50 mM sodium phosphate buffer pH 6.0, and 15
CV of 45% ethanol to eliminate adsorbed impurities. The Vi
polysaccharide was finally eluted with 1.5 CV of 50% ethanol,
0.4 M NaCl. Following elution, the polysaccharide was precipitated by addition of ethanol to a final concentration of 80% and
incubation for 20 min at RT. The precipitate was washed twice
with 80% ethanol prior to lyophilization. The protein and nucleic
acid content of the purified Vi polysaccharide was determined by
the bicinchoninic acid assay (BCA, Pierce) and UV spectroscopy
respectively.

eppendorf tubes. One half of the cells was fixed by resuspending
the pellet in 4% paraformaldehyde in PBS and incubation for
30 min at RT. Afterwards the fixed cells were washed 36 with
PBS and cell associated Vi was measured. The other half of the
washed cells was lysed using B-PER protein extraction reagents
(Pierce) according to manufacturer’s instructions. Protein and Vi
contents were measured in the cell lysate by the bicinchoninic acid
assay (BCA, Pierce) and ELISA. The amount of intracellular Vi
was defined using the difference in Vi measured in cell lysates and
in fixed cells. The Vi content of different samples was normalized
to the protein amount measured in the cell pellets.

Vi quantification by ELISA
Vi polysaccharide content of samples was measured using a
sandwich ELISA. Two monoclonal Vi specific mouse antibodies
P2B1G2/A9 (IgG1, coating antibody) and P5B2D8/A9 (IgM,
primary antibody) were used in the ELISA and are described
elsewhere [28]. In order to saturate the binding of the Vi to the
ELISA plate, the coating antibody P2B1G2/A9 was partially
purified from the hybridoma supernatant using a 5 ml HiTrap
Protein A HP column (GE Healthcare). Briefly, 50 ml of
P2B1G2/A9 hybridoma supernatant were diluted 1:10 with
binding buffer (20 mM sodium phosphate, pH 7.5) and loaded
on the Protein A column using a peristaltic pump at a flow rate of
20 ml min21. The column was eluted with 100 mM citric acid
pH 3.25 and 1 ml fractions were collected. The tubes destined to
collect the antibody fractions contained 100 ml 1 M Tris-HCl,
pH 9.0 to instantly neutralize the sample.
Flat bottom 96 well micro-titer plates (Nunc immuno MaxiSorb)
were coated with 50 ml of the partially purified antibody P2B1G2/
A9, diluted 1:100 in PBS, at 4uC overnight. The coating solution
was poured away and the plate was submerged and vigorously
agitated in 4000 ml of wash buffer (16 PBS with 0.05% Triton
6100). This washing step was performed at least 4 times to
completely wash out unbound antibody. Subsequently, the plate
was dried by spinning upside down in a micro plate rotor. This
washing procedure was always applied in further washing steps.
Each well was completely filled with 300 ml of blocking buffer (16
PBS with 2.5% BSA (globulin free BSA, Sigma, A7030)) and
incubated 2 h at RT on a plate shaker. After washing and drying
the plate the sample was applied in an appropriate dilution in
dilution buffer (16 PBS with 0.5% BSA). As a standard, Vi
polysaccharide (Typhim Vi, Sanofi Pasteur MSD) was used in
several dilutions in the range from 0–4 ng ml21. 100 ml of sample
and standard were applied in doublicates to the corresponding
wells and incubated 1 h at RT on a plate shaker. After washing
and drying the plate, 100 ml of the primary antibody (hybridoma
supernatant of P5B2D8/A9) diluted 1:100 in dilution buffer was
added to the wells and incubated 1 h at RT on a plate shaker.
After another washing and drying step the wells were incubated
with 100 ml of secondary antibody (goat anti-mouse IgM
peroxidase conjugated, Sigma A8786) diluted 1:2000 in dilution
buffer for 1 h at RT on a plate shaker. Following washing and
drying the reaction was developed with 100 ml of Ultra TMB
substrate (3,39,5,59-tetramethybenzidine liquid substrate, Pierce)
for 15 min and stopped with the addition 100 ml of 2 M sulphuric
acid. The bottom surface of the plate was wiped with 70% 2propanol and the absorption at 450 nm was measured.

Determination of O-acetyl content in the Vi
polysaccharide
The method was used as described elsewhere [30]. Briefly, the
O-acetyl groups were released by mild base treatment of the Vi
polysaccharide solution. The O-acetyl groups reacted with the
added hydroxylamine in alkali to form hydroxamic acid. The
formed hydroxamic acid was measured by the formation of a
purple-brown complex with Fe3+. Acetylcholine was used as a
standard.

Radiolabeling of Vi polysaccharide
Cells were cultured in LB medium supplemented with
antibiotics at 37uC in the shaker incubator (180 rpm). Cultures
were inoculated from an overnight culture to an A600 of 0.01. After
4 cell doublings, 1 mCi ml21 [3H]GlcNAc (American Radiolabeled Chemicals, Inc., ART 0142) was added and the culture was
incubated 2 h at 37uC in the shaker incubator. After incubation
the cells were centrifuged and the cell culture supernatant was
used to purify the labeled Vi polysaccharide as described above.
After drying of the purified Vi, the polysaccharide was
resuspended in 50 mM NaCl. Incorporation of radioactivity in
the purified samples was measured and normalized to the protein
content measured in the cell pellets.

Size exclusion chromatography
Sephacryl S-1000 (GE Lifescience) gel filtration medium was
used in a column with the proportions of 23 cm61.7 cm (height x
diameter). Chromatography was done by gravity flow using 50 mM
NaCl as the mobile phase and 1 ml fractions were collected.

Transmission Electron Microscopy (TEM)
TEM was done as described elsewhere [46].

Acknowledgments
We kindly thank Anke Willing for help with the screening for transposon
insertion mutants and the employees of GlycoVaxyn for scientific
discussion.

Vi polysaccharide purification
Vi polysaccharide was purified by a modified procedure as
described elsewhere [45]. The Vi was either purified from the cell
culture supernatant (in strains S. Typhi BRD948,
DH5a(pGVXN158) and DH5a(pGVXN158vexE::Tn5)) or from
PLOS ONE | www.plosone.org

Author Contributions
Conceived and designed the experiments: M. Wetter MK CJW GD M.
Wacker. Performed the experiments: M. Wetter DG DP. Analyzed the

10

September 2012 | Volume 7 | Issue 9 | e45609

Biosynthesis of the Vi Antigen of Salmonella Typhi

data: M. Wetter DG DP CJW GD M. Wacker. Contributed reagents/

materials/analysis tools: M. Wetter DG DP MK CJW. Wrote the paper:
M. Wetter GD M. Wacker.

References
24. Craigie J, Yen CH (1937) V bacteriophages for B. typhosus. Trans R Soc Can 5:
79–87.
25. Craigie J, Yen CH (1938) The demonstration of types of B. typhosus by means of
preparations of type II Vi phage. I. Principles and technique. Can Public
Health J 29: 448–463.
26. Desranleau JM (1949) Progress in the treatment of typhoid fever with Vi
bacteriophages. Can J Public Health 40: 473–478.
27. Brandis H, Imamura PS (1956) [Comparative studies of Vi-bacteriophages].
Z Hyg Infektionskr 143: 50–61.
28. Qadri A, Ghosh S, Talwar GP (1990) Monoclonal antibodies against two
discrete determinants on Vi capsular polysaccharide. J Immunoassay 11: 235–
250.
29. Taylor K (1965) Enzymatic deacetylation of Vi-polysaccharide by Vi-phage. II.
Biochem Biophys Res Commun 20: 752–756.
30. Hestrin S (1949) The reaction of acetylcholine and other carboxylic acid
derivatives with hydroxylamine, and its analytical application. J Biol Chem 180:
249–261.
31. Bergfeld AK, Claus H, Vogel U, Muhlenhoff M (2007) Biochemical
characterization of the polysialic acid-specific O-acetyltransferase NeuO of
Escherichia coli K1. J Biol Chem 282: 22217–22227.
32. Johnson EM, Baron LS (1969) Genetic transfer of the Vi antigen from
Salmonella typhosa to Escherichia coli. J Bacteriol 99: 358–359.
33. Pickard D, Toribio AL, Petty NK, van Tonder A, Yu L, et al. A conserved acetyl
esterase domain targets diverse bacteriophages to the Vi capsular receptor of
Salmonella enterica serovar Typhi. J Bacteriol 192: 5746–5754.
34. Friedman AM, Long SR, Brown SE, Buikema WJ, Ausubel FM (1982)
Construction of a broad host range cosmid cloning vector and its use in the
genetic analysis of Rhizobium mutants. Gene 18: 289–296.
35. Nair S, Alokam S, Kothapalli S, Porwollik S, Proctor E, et al. (2004) Salmonella
enterica serovar Typhi strains from which SPI7, a 134-kilobase island with genes
for Vi exopolysaccharide and other functions, has been deleted. J Bacteriol 186:
3214–3223.
36. Annunziato PW, Wright LF, Vann WF, Silver RP (1995) Nucleotide sequence
and genetic analysis of the neuD and neuB genes in region 2 of the polysialic
acid gene cluster of Escherichia coli K1. J Bacteriol 177: 312–319.
37. Troy FA, 2nd (1992) Polysialylation: from bacteria to brains. Glycobiology 2: 5–
23.
38. Pavelka MS, Jr., Hayes SF, Silver RP (1994) Characterization of KpsT, the
ATP-binding component of the ABC-transporter involved with the export of
capsular polysialic acid in Escherichia coli K1. J Biol Chem 269: 20149–20158.
39. Rigg GP, Barrett B, Roberts IS (1998) The localization of KpsC, S and T, and
KfiA, C and D proteins involved in the biosynthesis of the Escherichia coli K5
capsular polysaccharide: evidence for a membrane-bound complex. Microbiology 144 (Pt 10): 2905–2914.
40. Steenbergen SM, Vimr ER (2008) Biosynthesis of the Escherichia coli K1 group
2 polysialic acid capsule occurs within a protected cytoplasmic compartment.
Mol Microbiol 68: 1252–1267.
41. Bronner D, Sieberth V, Pazzani C, Roberts IS, Boulnois GJ, et al. (1993)
Expression of the capsular K5 polysaccharide of Escherichia coli: biochemical
and electron microscopic analyses of mutants with defects in region 1 of the K5
gene cluster. J Bacteriol 175: 5984–5992.
42. Wunder DE, Aaronson W, Hayes SF, Bliss JM, Silver RP (1994) Nucleotide
sequence and mutational analysis of the gene encoding KpsD, a periplasmic
protein involved in transport of polysialic acid in Escherichia coli K1. J Bacteriol
176: 4025–4033.
43. Bliss JM, Garon CF, Silver RP (1996) Polysialic acid export in Escherichia coli
K1: the role of KpsT, the ATP-binding component of an ABC transporter, in
chain translocation. Glycobiology 6: 445–452.
44. Hone DM, Harris AM, Chatfield S, Dougan G, Levine MM (1991)
Construction of genetically defined double aro mutants of Salmonella typhi.
Vaccine 9: 810–816.
45. Demil P, D’Hondt E, Van Hoecke C (2003) Salmonella Typhi vaccine
compositions. EP 1 107 787 B1.
46. Jansen AM, Hall LJ, Clare S, Goulding D, Holt KE, et al. A Salmonella
Typhimurium-Typhi genomic chimera: a model to study Vi polysaccharide
capsule function in vivo. PLoS Pathog 7: e1002131.

1. Looney RJ, Steigbigel RT (1986) Role of the Vi antigen of Salmonella typhi in
resistance to host defense in vitro. J Lab Clin Med 108: 506–516.
2. Robbins JD, Robbins JB (1984) Reexamination of the protective role of the
capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 150: 436–
449.
3. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, et al.
(1970) Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med
283: 739–746.
4. Hone DM, Attridge SR, Forrest B, Morona R, Daniels D, et al. (1988) A galE
via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in
humans. Infect Immun 56: 1326–1333.
5. Arya SC (2002) Field effectiveness of Vi polysaccharide typhoid vaccine in the
People’s Republic of China. J Infect Dis 185: 845; author reply 845–846.
6. Engels EA, Falagas ME, Lau J, Bennish ML (1998) Typhoid fever vaccines: a
meta-analysis of studies on efficacy and toxicity. Bmj 316: 110–116.
7. Szu SC, Li XR, Stone AL, Robbins JB (1991) Relation between structure and
immunologic properties of the Vi capsular polysaccharide. Infect Immun 59:
4555–4561.
8. Szu SC, Bystricky S (2003) Physical, chemical, antigenic, and immunologic
characterization of polygalacturonan, its derivatives, and Vi antigen from
Salmonella typhi. Methods Enzymol 363: 552–567.
9. Hashimoto Y, Ezaki T, Li N, Yamamoto H (1991) Molecular cloning of the
ViaB region of Salmonella typhi. FEMS Microbiol Lett 69: 53–56.
10. Pickard D, Wain J, Baker S, Line A, Chohan S, et al. (2003) Composition,
acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella
enterica pathogenicity island SPI-7. J Bacteriol 185: 5055–5065.
11. Whitfield C (2006) Biosynthesis and assembly of capsular polysaccharides in
Escherichia coli. Annu Rev Biochem 75: 39–68.
12. Houng HS, Noon KF, Ou JT, Baron LS (1992) Expression of Vi antigen in
Escherichia coli K-12: characterization of ViaB from Citrobacter freundii and
identity of ViaA with RcsB. J Bacteriol 174: 5910–5915.
13. Virlogeux I, Waxin H, Ecobichon C, Lee JO, Popoff MY (1996) Characterization of the rcsA and rcsB genes from Salmonella typhi: rcsB through tviA is
involved in regulation of Vi antigen synthesis. J Bacteriol 178: 1691–1698.
14. Pickard D, Li J, Roberts M, Maskell D, Hone D, et al. (1994) Characterization of
defined ompR mutants of Salmonella typhi: ompR is involved in the regulation
of Vi polysaccharide expression. Infect Immun 62: 3984–3993.
15. Hashimoto Y, Li N, Yokoyama H, Ezaki T (1993) Complete nucleotide
sequence and molecular characterization of ViaB region encoding Vi antigen in
Salmonella typhi. J Bacteriol 175: 4456–4465.
16. Arricau N, Hermant D, Waxin H, Ecobichon C, Duffey PS, et al. (1998) The
RcsB-RcsC regulatory system of Salmonella typhi differentially modulates the
expression of invasion proteins, flagellin and Vi antigen in response to
osmolarity. Mol Microbiol 29: 835–850.
17. Virlogeux I, Waxin H, Ecobichon C, Popoff MY (1995) Role of the viaB locus in
synthesis, transport and expression of Salmonella typhi Vi antigen. Microbiology
141 (Pt 12): 3039–3047.
18. Zhang H, Zhou Y, Bao H, Liu HW (2006) Vi antigen biosynthesis in Salmonella
typhi: characterization of UDP-N-acetylglucosamine C-6 dehydrogenase (TviB)
and UDP-N-acetylglucosaminuronic acid C-4 epimerase (TviC). Biochemistry
45: 8163–8173.
19. Cuthbertson L, Mainprize IL, Naismith JH, Whitfield C (2009) Pivotal roles of
the outer membrane polysaccharide export and polysaccharide copolymerase
protein families in export of extracellular polysaccharides in gram-negative
bacteria. Microbiol Mol Biol Rev 73: 155–177.
20. Dong C, Beis K, Nesper J, Brunkan-Lamontagne AL, Clarke BR, et al. (2006)
Wza the translocon for E. coli capsular polysaccharides defines a new class of
membrane protein. Nature 444: 226–229.
21. Sathiyamoorthy K, Mills E, Franzmann TM, Rosenshine I, Saper MA (2011)
The crystal structure of Escherichia coli group 4 capsule protein GfcC reveals a
domain organization resembling that of Wza. Biochemistry 50: 5465–5476.
22. Bliss JM, Silver RP (1996) Coating the surface: a model for expression of
capsular polysialic acid in Escherichia coli K1. Mol Microbiol 21: 221–231.
23. Craigie J, Brandon KF (1936) Bacteriophage specific for the O-resistant V form
of B. typhosus. J Pathol Bacteriol 43: 233–248.

PLOS ONE | www.plosone.org

11

September 2012 | Volume 7 | Issue 9 | e45609

